vs
ALTISOURCE PORTFOLIO SOLUTIONS S.A.（ASPS）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ALTISOURCE PORTFOLIO SOLUTIONS S.A.的季度营收约是ARS Pharmaceuticals, Inc.的1.5倍（$42.3M vs $28.1M），ALTISOURCE PORTFOLIO SOLUTIONS S.A.净利率更高（-16.8% vs -147.1%，领先130.3%），ALTISOURCE PORTFOLIO SOLUTIONS S.A.同比增速更快（3.2% vs -67.6%）
Altisource Portfolio Solutions S.A.是面向抵押贷款、房地产及消费金融领域的全球服务商，为贷款机构、服务商、投资者等市场参与者提供技术、数据与运营解决方案，优化资产管理、房产交易等业务流程，提升客户运营效率。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
ASPS vs SPRY — 直观对比
营收规模更大
ASPS
是对方的1.5倍
$28.1M
营收增速更快
ASPS
高出70.8%
-67.6%
净利率更高
ASPS
高出130.3%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.3M | $28.1M |
| 净利润 | $-7.1M | $-41.3M |
| 毛利率 | 26.5% | — |
| 营业利润率 | -15.5% | -147.6% |
| 净利率 | -16.8% | -147.1% |
| 营收同比 | 3.2% | -67.6% |
| 净利润同比 | 18.2% | -182.8% |
| 每股收益（稀释后） | $-1.02 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPSSPRY
| Q4 25 | $42.3M | $28.1M | ||
| Q3 25 | $41.9M | $32.5M | ||
| Q2 25 | $43.3M | $15.7M | ||
| Q1 25 | $43.4M | $8.0M | ||
| Q4 24 | $41.0M | $86.6M | ||
| Q3 24 | $40.5M | $2.1M | ||
| Q2 24 | $39.1M | $500.0K | ||
| Q1 24 | $39.5M | $0 |
净利润ASPSSPRY
| Q4 25 | $-7.1M | $-41.3M | ||
| Q3 25 | $-2.3M | $-51.2M | ||
| Q2 25 | $16.7M | $-44.9M | ||
| Q1 25 | $-5.3M | $-33.9M | ||
| Q4 24 | $-8.7M | $49.9M | ||
| Q3 24 | $-9.3M | $-19.1M | ||
| Q2 24 | $-8.3M | $-12.5M | ||
| Q1 24 | $-9.2M | $-10.3M |
毛利率ASPSSPRY
| Q4 25 | 26.5% | — | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 30.1% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 30.3% | — | ||
| Q3 24 | 29.8% | — | ||
| Q2 24 | 32.5% | — | ||
| Q1 24 | 31.2% | — |
营业利润率ASPSSPRY
| Q4 25 | -15.5% | -147.6% | ||
| Q3 25 | 1.2% | -163.7% | ||
| Q2 25 | 7.5% | -302.9% | ||
| Q1 25 | 7.5% | -466.3% | ||
| Q4 24 | 1.4% | 54.5% | ||
| Q3 24 | 2.7% | -1051.6% | ||
| Q2 24 | 5.3% | -3068.0% | ||
| Q1 24 | -1.4% | — |
净利率ASPSSPRY
| Q4 25 | -16.8% | -147.1% | ||
| Q3 25 | -5.5% | -157.4% | ||
| Q2 25 | 38.5% | -285.6% | ||
| Q1 25 | -12.1% | -425.7% | ||
| Q4 24 | -21.3% | 57.7% | ||
| Q3 24 | -23.0% | -925.0% | ||
| Q2 24 | -21.1% | -2503.2% | ||
| Q1 24 | -23.2% | — |
每股收益（稀释后）ASPSSPRY
| Q4 25 | $-1.02 | $-0.41 | ||
| Q3 25 | $-0.22 | $-0.52 | ||
| Q2 25 | $1.48 | $-0.46 | ||
| Q1 25 | $-0.09 | $-0.35 | ||
| Q4 24 | $-4.72 | $0.52 | ||
| Q3 24 | $-2.61 | $-0.20 | ||
| Q2 24 | $-2.33 | $-0.13 | ||
| Q1 24 | $-0.33 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.6M | $245.0M |
| 总债务越低越好 | $191.1M | $96.4M |
| 股东权益账面价值 | $-110.2M | $114.3M |
| 总资产 | $139.8M | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资ASPSSPRY
| Q4 25 | $26.6M | $245.0M | ||
| Q3 25 | $28.6M | $288.2M | ||
| Q2 25 | $30.0M | $240.1M | ||
| Q1 25 | $30.8M | $275.7M | ||
| Q4 24 | $29.8M | $314.0M | ||
| Q3 24 | $28.3M | $204.6M | ||
| Q2 24 | $29.7M | $218.7M | ||
| Q1 24 | $29.6M | $223.6M |
总债务ASPSSPRY
| Q4 25 | $191.1M | $96.4M | ||
| Q3 25 | $192.5M | $96.2M | ||
| Q2 25 | $193.9M | — | ||
| Q1 25 | $195.0M | — | ||
| Q4 24 | $230.5M | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPSSPRY
| Q4 25 | $-110.2M | $114.3M | ||
| Q3 25 | $-104.2M | $147.7M | ||
| Q2 25 | $-102.7M | $192.3M | ||
| Q1 25 | $-119.8M | $229.0M | ||
| Q4 24 | $-157.4M | $256.8M | ||
| Q3 24 | $-149.4M | $201.0M | ||
| Q2 24 | $-140.8M | $215.2M | ||
| Q1 24 | $-133.3M | $223.9M |
总资产ASPSSPRY
| Q4 25 | $139.8M | $327.7M | ||
| Q3 25 | $139.9M | $372.8M | ||
| Q2 25 | $142.9M | $313.5M | ||
| Q1 25 | $145.7M | $327.3M | ||
| Q4 24 | $143.6M | $351.2M | ||
| Q3 24 | $144.5M | $217.6M | ||
| Q2 24 | $146.6M | $222.0M | ||
| Q1 24 | $148.9M | $227.6M |
负债/权益比ASPSSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-505.0K | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $-525.0K | — |
| 自由现金流率自由现金流/营收 | -1.2% | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-5.1M | — |
8季度趋势，按日历期对齐
经营现金流ASPSSPRY
| Q4 25 | $-505.0K | $-43.5M | ||
| Q3 25 | $718.0K | $-47.0M | ||
| Q2 25 | $-306.0K | $-39.6M | ||
| Q1 25 | $-5.0M | $-40.7M | ||
| Q4 24 | $-1.4M | $42.0M | ||
| Q3 24 | $-1.6M | $-14.5M | ||
| Q2 24 | $180.0K | $-7.3M | ||
| Q1 24 | $-2.2M | $-6.7M |
自由现金流ASPSSPRY
| Q4 25 | $-525.0K | — | ||
| Q3 25 | $697.0K | $-47.2M | ||
| Q2 25 | $-309.0K | $-39.6M | ||
| Q1 25 | $-5.0M | $-40.8M | ||
| Q4 24 | $-1.4M | $41.7M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-6.8M |
自由现金流率ASPSSPRY
| Q4 25 | -1.2% | — | ||
| Q3 25 | 1.7% | -145.4% | ||
| Q2 25 | -0.7% | -252.2% | ||
| Q1 25 | -11.5% | -512.1% | ||
| Q4 24 | -3.4% | 48.2% | ||
| Q3 24 | — | -706.3% | ||
| Q2 24 | — | -1463.4% | ||
| Q1 24 | — | — |
资本支出强度ASPSSPRY
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.1% | 1.1% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 6.8% | ||
| Q2 24 | 0.0% | 7.6% | ||
| Q1 24 | 0.0% | — |
现金转化率ASPSSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPS
| Services | $39.9M | 94% |
| Revenue Relatedto Technology Platformsand Professional Services | $2.4M | 6% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
